Biokraft International AB (publ) reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was SEK 149.07 million compared to SEK 112.8 million a year ago. Revenue was SEK 163.33 million compared to SEK 130.09 million a year ago.

Net loss was SEK 33.61 million compared to SEK 58.64 million a year ago. Basic loss per share from continuing operations was SEK 0.79 compared to SEK 1.35 a year ago.